Back to top

Regenxbio (RGNX) in Focus: Stock Moves 9.5% Higher
September 06, 2017

Read MoreHide Full Article

Regenxbio Inc.(RGNX - Free Report) was a big mover last session, as the company saw its shares rise more than 9% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This continues the recent uptrend for the company —as the stock is now up 33.3% in the past one-month time frame.

The company has not seen any changes in estimate revision over the past few weeks, while the Zacks Consensus Estimate for the current quarter hasn’t been in a trend either. The recent price action is encouraging though, so make sure to keep a close watch on this firm in the near future.

Regenxbio currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

A better-ranked stock in the retail sector is Akari Therapeutics (AKTX - Free Report) , which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

Is RGNX going up? Or down? Predict to see what others think: Up or Down

4 Surprising Tech Stocks to Keep an Eye On

Tech stocks have been a major force behind the market’s record highs, but picking the best ones to buy can be tough. There’s a simple way to invest in the success of the entire sector. Zacks has just released a Special Report revealing one thing tech companies literally cannot function without. More importantly, it reveals 4 top stocks set to skyrocket on increasing demand for these devices. I encourage you to get the report now – before the next wave of innovations really takes off.

See Stocks Now>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


REGENXBIO Inc. (RGNX) - free report >>

Akari Therapeutics PLC (AKTX) - free report >>


More from Zacks Tale of the Tape

You May Like